Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

J. L. Goldstein, H. G. Schrott, W. R. Hazzard, E. L. Bierman, A. G. Motulsky

Research output: Contribution to journalArticle

1027 Citations (Scopus)

Abstract

To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these - familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia - appeared to represent dominant expression of three different autosomal genes, occurring in about 20% of survivors below 60 yr of age and 7% of all older survivors. Two other disorders - polygenic hypercholesterolemia and sporadic hypertriglyceridemia - each affected about 6% of survivors in both age groups. The most common genetic form of hyperlipidemia identified in this study has hitherto been poorly defined and has been designated as familial combined hyperlipidemia. Affected family members characteristically had elevated levels of both cholesterol and triglyceride. However, increased cholesterol or increased triglyceride levels alone were also frequently observed. The combined disorder was shown to be genetically distinct from familial hypercholesterolemia and familial hypertriglyceridemia for the following reasons: (a) the distribution pattern of cholesterol and triglyceride levels in relatives of probands was unique; (b) children of individuals with combined hyperlipidemia did not express hypercholesterolemia in contrast to the finding of hypercholesterolemic children from families with familial hypercholesterolemia; and (c) analysis of informative matings suggested that the different lipid phenotypes owed their origin to variable expression of a single autosomal dominant gene and not to segregation of two separate genes, such as one elevating the level of cholesterol and the other elevating the level of triglyceride. Heterozygosity for one of the three lipid elevating genes identified in this study may have a frequency in the general population of about 1%, constituting a major problem in early diagnosis and preventive therapy.

Original languageEnglish (US)
Pages (from-to)1544-1568
Number of pages25
JournalJournal of Clinical Investigation
Volume52
Issue number7
StatePublished - 1973

Fingerprint

Hyperlipidemias
Coronary Disease
Triglycerides
Lipids
Cholesterol
Hyperlipoproteinemia Type II
Survivors
Familial Combined Hyperlipidemia
Hyperlipoproteinemia Type IV
Hypercholesterolemia
Genes
Dominant Genes
Hypertriglyceridemia
Spouses
Early Diagnosis
Fasting
Age Groups
Myocardial Infarction
Phenotype
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. / Goldstein, J. L.; Schrott, H. G.; Hazzard, W. R.; Bierman, E. L.; Motulsky, A. G.

In: Journal of Clinical Investigation, Vol. 52, No. 7, 1973, p. 1544-1568.

Research output: Contribution to journalArticle

@article{370b96b7056e4f70949f2b8830bd2ab7,
title = "Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia",
abstract = "To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these - familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia - appeared to represent dominant expression of three different autosomal genes, occurring in about 20{\%} of survivors below 60 yr of age and 7{\%} of all older survivors. Two other disorders - polygenic hypercholesterolemia and sporadic hypertriglyceridemia - each affected about 6{\%} of survivors in both age groups. The most common genetic form of hyperlipidemia identified in this study has hitherto been poorly defined and has been designated as familial combined hyperlipidemia. Affected family members characteristically had elevated levels of both cholesterol and triglyceride. However, increased cholesterol or increased triglyceride levels alone were also frequently observed. The combined disorder was shown to be genetically distinct from familial hypercholesterolemia and familial hypertriglyceridemia for the following reasons: (a) the distribution pattern of cholesterol and triglyceride levels in relatives of probands was unique; (b) children of individuals with combined hyperlipidemia did not express hypercholesterolemia in contrast to the finding of hypercholesterolemic children from families with familial hypercholesterolemia; and (c) analysis of informative matings suggested that the different lipid phenotypes owed their origin to variable expression of a single autosomal dominant gene and not to segregation of two separate genes, such as one elevating the level of cholesterol and the other elevating the level of triglyceride. Heterozygosity for one of the three lipid elevating genes identified in this study may have a frequency in the general population of about 1{\%}, constituting a major problem in early diagnosis and preventive therapy.",
author = "Goldstein, {J. L.} and Schrott, {H. G.} and Hazzard, {W. R.} and Bierman, {E. L.} and Motulsky, {A. G.}",
year = "1973",
language = "English (US)",
volume = "52",
pages = "1544--1568",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "7",

}

TY - JOUR

T1 - Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

AU - Goldstein, J. L.

AU - Schrott, H. G.

AU - Hazzard, W. R.

AU - Bierman, E. L.

AU - Motulsky, A. G.

PY - 1973

Y1 - 1973

N2 - To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these - familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia - appeared to represent dominant expression of three different autosomal genes, occurring in about 20% of survivors below 60 yr of age and 7% of all older survivors. Two other disorders - polygenic hypercholesterolemia and sporadic hypertriglyceridemia - each affected about 6% of survivors in both age groups. The most common genetic form of hyperlipidemia identified in this study has hitherto been poorly defined and has been designated as familial combined hyperlipidemia. Affected family members characteristically had elevated levels of both cholesterol and triglyceride. However, increased cholesterol or increased triglyceride levels alone were also frequently observed. The combined disorder was shown to be genetically distinct from familial hypercholesterolemia and familial hypertriglyceridemia for the following reasons: (a) the distribution pattern of cholesterol and triglyceride levels in relatives of probands was unique; (b) children of individuals with combined hyperlipidemia did not express hypercholesterolemia in contrast to the finding of hypercholesterolemic children from families with familial hypercholesterolemia; and (c) analysis of informative matings suggested that the different lipid phenotypes owed their origin to variable expression of a single autosomal dominant gene and not to segregation of two separate genes, such as one elevating the level of cholesterol and the other elevating the level of triglyceride. Heterozygosity for one of the three lipid elevating genes identified in this study may have a frequency in the general population of about 1%, constituting a major problem in early diagnosis and preventive therapy.

AB - To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these - familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia - appeared to represent dominant expression of three different autosomal genes, occurring in about 20% of survivors below 60 yr of age and 7% of all older survivors. Two other disorders - polygenic hypercholesterolemia and sporadic hypertriglyceridemia - each affected about 6% of survivors in both age groups. The most common genetic form of hyperlipidemia identified in this study has hitherto been poorly defined and has been designated as familial combined hyperlipidemia. Affected family members characteristically had elevated levels of both cholesterol and triglyceride. However, increased cholesterol or increased triglyceride levels alone were also frequently observed. The combined disorder was shown to be genetically distinct from familial hypercholesterolemia and familial hypertriglyceridemia for the following reasons: (a) the distribution pattern of cholesterol and triglyceride levels in relatives of probands was unique; (b) children of individuals with combined hyperlipidemia did not express hypercholesterolemia in contrast to the finding of hypercholesterolemic children from families with familial hypercholesterolemia; and (c) analysis of informative matings suggested that the different lipid phenotypes owed their origin to variable expression of a single autosomal dominant gene and not to segregation of two separate genes, such as one elevating the level of cholesterol and the other elevating the level of triglyceride. Heterozygosity for one of the three lipid elevating genes identified in this study may have a frequency in the general population of about 1%, constituting a major problem in early diagnosis and preventive therapy.

UR - http://www.scopus.com/inward/record.url?scp=0015796295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015796295&partnerID=8YFLogxK

M3 - Article

C2 - 4718953

AN - SCOPUS:0015796295

VL - 52

SP - 1544

EP - 1568

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 7

ER -